Home » Glycopyrrolate Injection, USP
Indication and Important Safety Information you should know about Glycopyrrolate Injection, USP
Adverse events should be reported to Piramal Critical Care at www.piramalcriticalcare.com/complaints
You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit MedWatch or call 1-800-FDA-1088.
Learn more about upcoming events, new press releases, and the latest news from Piramal Critical Care.